查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1421669

癌症活檢市場、份額、規模、趨勢、行業分析報告：按產品類型、應用、地區、細分市場預測，2024-2032 年

Cancer Biopsy Market Share, Size, Trends, Industry Analysis Report, By Type (Liquid, Biopsy, Tissue Biopsy, and Others); By Product Type; By Application; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，到 2032 年，全球癌症活檢市場規模預計將達到 920.9 億美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

活檢是一種從身體任何部位取出組織以檢測疾病的醫療程序。 使用多種方法，包括針頭收集和手術收集。 MRI 和 CT 掃描等影像學檢查可以識別異常情況，但無法區分癌細胞和非癌細胞。 因此，活檢對於確認惡性腫瘤的診斷至關重要，並涉及詳細的細胞分析。

體液切片的進步正在顯著影響癌症活檢市場的成長。 這項創新技術分析血液中的遺傳物質，以便可以採用非侵入性方法來檢測和監測特定的癌症類型。

活檢提供了對不同癌症類型的生物學特性的重要見解。 這些資訊可用於確定潛在的藥物標靶和規劃臨床試驗以評估新療法。 活檢也用於監測治療反應並確定抗藥性機制，有助於開發更有效的藥物和聯合療法。

癌症切片市場面臨許多挑戰。 先進的活檢技術和分子分析技術在資源有限的地區並不容易取得。 此外，解釋複雜的基因組數據需要專業知識，這凸顯了腫瘤學繼續教育和培訓的必要性。 侵入性活檢程序可能會給患者帶來不適，導致患者不願意接受該程序。 此外，對於某些個人和衛生系統來說，活檢程序和相關技術的成本可能太高。 克服這些挑戰對於確保平等獲得優質活檢服務並最大限度地提高癌症診斷和治療的有效性至關重要。

癌症切片市場報告亮點

  • 由於廣泛使用，液體活檢領域預計在預測期內將以最高複合年增長率增長。
  • 套件和耗材細分市場在 2022 年佔據最大的市場份額，這主要是由於成本效益和高性能。
  • 乳癌細分市場在 2022 年佔據了很大的市場收入份額，這主要是由於其高盛行率。
  • 到 2022 年，北美地區將佔據大部分市場；

目錄

第1章簡介

第 2 章執行摘要

第3章研究方法

第 4 章全球癌症切片市場洞察

  • 癌症切片市場－應用概況
  • 癌症切片市場動態
    • 推動者和機會
      • 癌症患者的增加預計將刺激產品需求
      • 分子診斷方法的進展
    • 抑制因素和挑戰
      • 與癌症切片相關的高成本
  • PESTEL 分析
  • 癌症切片市場的應用趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第 5 章全球癌症切片市場（按類型）

  • 主要調查結果
  • 簡介
  • 體液切片
  • 組織切片
  • 其他

第 6 章全球癌症切片市場（依產品類型）

  • 主要調查結果
  • 簡介
  • 套件和消耗品
  • 設備
  • 服務

第 7 章全球癌症切片市場（按應用）

  • 主要調查結果
  • 簡介
  • 乳癌
  • 子宮頸癌
  • 肺癌
  • 大腸直腸癌
  • 其他

第 8 章全球癌症切片市場（按地區）

  • 主要調查結果
  • 簡介
    • 2019-2032 年癌症切片市場評估（按地區）
  • 癌症切片市場 - 北美
    • 北美：2019-2032 年癌症切片市場（按類型）
    • 北美：癌症活檢市場，按應用劃分，2019-2032 年
    • 北美：癌症切片市場，依產品類型，2019-2032 年
    • 癌症切片市場－美國
    • 癌症切片市場 - 加拿大
  • 癌症切片市場 - 歐洲
    • 歐洲：2019-2032 年癌症切片市場（按類型）
    • 歐洲：癌症活檢市場，按應用劃分，2019-2032 年
    • 歐洲：癌症切片市場（按產品類型），2019-2032 年
    • 癌症切片市場－英國
    • 癌症切片市場 - 法國
    • 癌症切片市場 - 德國
    • 癌症切片市場 - 義大利
    • 癌症切片市場 - 西班牙
    • 癌症切片市場 - 荷蘭
    • 癌症切片市場 - 俄羅斯
  • 癌症切片市場 - 亞太地區
    • 亞太地區：癌症切片市場（按類型），2019-2032 年
    • 亞太地區：癌症活檢市場，按應用劃分，2019-2032 年
    • 亞太地區：癌症切片市場（依產品類型），2019-2032 年
    • 中國癌症切片市場
    • 癌症切片市場 - 印度
    • 癌症切片市場 - 馬來西亞
    • 癌症切片市場 - 日本
    • 印尼癌症切片市場
    • 韓國癌症切片市場
  • 癌症切片市場 - 中東和非洲
    • 中東和非洲：癌症活檢市場（按類型），2019-2032 年
    • 中東和非洲：癌症活檢市場，按應用劃分，2019-2032 年
    • 中東和非洲：癌症活檢市場（按產品類型），2019-2032 年
    • 癌症切片市場 - 沙烏地阿拉伯
    • 癌症切片市場 - 阿拉伯聯合大公國
    • 癌症切片市場 - 以色列
    • 癌症切片市場 - 南非
  • 癌症切片市場 - 拉丁美洲
    • 拉丁美洲：2019-2032 年癌症切片市場（按類型）
    • 拉丁美洲：癌症活檢市場，按應用劃分，2019-2032 年
    • 拉丁美洲：癌症活檢市場，按產品類型劃分，2019-2032 年
    • 癌症切片市場 - 墨西哥
    • 癌症切片市場 - 巴西
    • 癌症切片市場 - 阿根廷

第9章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第10章公司簡介

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • Myriad Genetics, Inc.
  • NeoGenomics, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Veracyte, Inc.
Product Code: PM4004

The global cancer biopsy market size is expected to reach USD 92.09 billion by 2032, according to a new study by Polaris Market Research. The report "Cancer Biopsy Market Share, Size, Trends, Industry Analysis Report, By Type (Liquid, Biopsy, Tissue Biopsy, and Others); By Product Type; By Application; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

A biopsy is a medical procedure that involves extracting tissue from any part of the body to detect diseases. Different methods, including needle-based or surgical extraction, are used. Imaging tests such as MRIs and CT scans can identify abnormalities, but they cannot differentiate between cancerous and non-cancerous cells. Therefore, biopsies are essential to confirm malignancy diagnoses and involve detailed cellular analysis.

Advancements in liquid biopsies have significantly influenced the growth of the cancer biopsy market. This innovative technique analyzes genetic material in the bloodstream, making it possible to detect and monitor specific cancer types in a non-invasive approach.

Biopsies offer crucial insights into the biology of different cancer types. This information is instrumental in identifying potential drug targets and designing clinical trials to evaluate new therapies. Biopsies are also used to monitor treatment response and identify mechanisms of resistance, contributing to the development of more effective drugs and combination therapies.

The cancer biopsy market is facing numerous challenges. Advanced biopsy techniques and molecular profiling technologies are not readily available in areas with limited resources. Additionally, interpreting complex genomic data requires specialized expertise, which highlights the need for ongoing education and training in oncology. Invasive biopsy procedures can cause discomfort to patients, leading to reluctance to undergo the process. Moreover, the cost of biopsy procedures and related technologies can be too high for some individuals and healthcare systems. It is vital to overcome these challenges to ensure equal access to high-quality biopsy services and to maximize their impact on cancer diagnosis and treatment.

Cancer Biopsy Market Report Highlights

  • The liquid biopsy segment is expected to grow at the highest CAGR during the projected period on account of wide usage
  • The kits and consumables segment accounted for the largest market share in 2022, which is mainly driven by cost-effectiveness and higher performance.
  • The breast cancer segment held a significant market revenue share in 2022, mainly due to its high prevalence rate
  • North America region dominated the market with a majority share in 2022, owing to exponential growth in the technology and advanced healthcare system
  • The global key market players include: Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc

Polaris Market Research has segmented the cancer biopsy market report based on type, product type, application, and region:

Cancer Biopsy, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Liquid, Biopsy
  • Tissue Biopsy
  • Others

Cancer Biopsy, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Kits and Consumables
  • Instruments
  • Services

Cancer Biopsy, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Breast Cancer
  • Cervical Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Others

Cancer Biopsy, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cancer Biopsy Market Insights

  • 4.1. Cancer Biopsy Market - Application Snapshot
  • 4.2. Cancer Biopsy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase in cancer cases is projected to spur the product demand
      • 4.2.1.2. Advancements in molecular diagnostics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High costs associated with cancer biopsy tests
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cancer Biopsy Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cancer Biopsy Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Liquid, Biopsy
    • 5.3.1. Global Cancer Biopsy Market, by Liquid, Biopsy, by Region, 2019-2032 (USD Billion)
  • 5.4. Tissue Biopsy
    • 5.4.1. Global Cancer Biopsy Market, by Tissue Biopsy, by Region, 2019-2032 (USD Billion)
  • 5.5. Others
    • 5.5.1. Global Cancer Biopsy Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Cancer Biopsy Market, by Product Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 6.3. Kits and Consumables
    • 6.3.1. Global Cancer Biopsy Market, by Kits and Consumables, by Region, 2019-2032 (USD Billion)
  • 6.4. Instruments
    • 6.4.1. Global Cancer Biopsy Market, by Instruments, by Region, 2019-2032 (USD Billion)
  • 6.5. Services
    • 6.5.1. Global Cancer Biopsy Market, by Services, by Region, 2019-2032 (USD Billion)

7. Global Cancer Biopsy Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • 7.3. Breast Cancer
    • 7.3.1. Global Cancer Biopsy Market, by Breast Cancer, By Region, 2019-2032 (USD Billion)
  • 7.4. Cervical Cancer
    • 7.4.1. Global Cancer Biopsy Market, by Cervical Cancer, By Region, 2019-2032 (USD Billion)
  • 7.5. Lung Cancer
    • 7.5.1. Global Cancer Biopsy Market, by Lung Cancer, By Region, 2019-2032 (USD Billion)
  • 7.6. Colorectal Cancer
    • 7.6.1. Global Cancer Biopsy Market, by Colorectal Cancer, By Region, 2019-2032 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Cancer Biopsy Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Cancer Biopsy Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Cancer Biopsy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Cancer Biopsy Market - North America
    • 8.3.1. North America: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.3.3. North America: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.3.4. Cancer Biopsy Market - U.S.
      • 8.3.4.1. U.S.: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.3.5. Cancer Biopsy Market - Canada
      • 8.3.5.1. Canada: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.4. Cancer Biopsy Market - Europe
    • 8.4.1. Europe: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.4. Cancer Biopsy Market - UK
      • 8.4.4.1. UK: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.5. Cancer Biopsy Market - France
      • 8.4.5.1. France: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.6. Cancer Biopsy Market - Germany
      • 8.4.6.1. Germany: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.7. Cancer Biopsy Market - Italy
      • 8.4.7.1. Italy: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.8. Cancer Biopsy Market - Spain
      • 8.4.8.1. Spain: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.9. Cancer Biopsy Market - Netherlands
      • 8.4.9.1. Netherlands: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.10. Cancer Biopsy Market - Russia
      • 8.4.10.1. Russia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.5. Cancer Biopsy Market - Asia Pacific
    • 8.5.1. Asia Pacific: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.4. Cancer Biopsy Market - China
      • 8.5.4.1. China: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.5. Cancer Biopsy Market - India
      • 8.5.5.1. India: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.6. Cancer Biopsy Market - Malaysia
      • 8.5.6.1. Malaysia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.7. Cancer Biopsy Market - Japan
      • 8.5.7.1. Japan: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.8. Cancer Biopsy Market - Indonesia
      • 8.5.8.1. Indonesia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.9. Cancer Biopsy Market - South Korea
      • 8.5.9.1. South Korea: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.6. Cancer Biopsy Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.4. Cancer Biopsy Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.5. Cancer Biopsy Market - UAE
      • 8.6.5.1. UAE: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.6. Cancer Biopsy Market - Israel
      • 8.6.6.1. Israel: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.7. Cancer Biopsy Market - South Africa
      • 8.6.7.1. South Africa: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.7. Cancer Biopsy Market - Latin America
    • 8.7.1. Latin America: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.4. Cancer Biopsy Market - Mexico
      • 8.7.4.1. Mexico: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.5. Cancer Biopsy Market - Brazil
      • 8.7.5.1. Brazil: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.6. Cancer Biopsy Market - Argentina
      • 8.7.6.1. Argentina: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Becton, Dickinson and Company
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bio-Rad Laboratories, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Danaher Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. F. Hoffmann-La Roche Ltd.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Hologic, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Illumina, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Koninklijke Philips N.V.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Myriad Genetics, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. NeoGenomics, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. QIAGEN N.V.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Siemens Healthineers AG
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Sysmex Corporation
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Thermo Fisher Scientific Inc.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Veracyte, Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables

  • Table 1 Global Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 2 Global Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 3 Global Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 4 Cancer Biopsy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 6 North America: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 7 North America: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 8 U.S.: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 11 Canada: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 13 Canada: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 14 Europe: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 16 Europe: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 17 UK: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 18 UK: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 19 UK: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 20 France: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 21 France: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 22 France: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 23 Germany: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 25 Germany: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 26 Italy: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 28 Italy: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 29 Spain: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 31 Spain: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 35 Russia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 37 Russia: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 41 China: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 42 China: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 43 China: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 44 India: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 45 India: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 46 India: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 50 Japan: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 52 Japan: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 56 South Korea: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 58 South Korea: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 65 UAE: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 67 UAE: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 68 Israel: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 70 Israel: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 71 South Africa: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 73 South Africa: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 74 Latin America: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 76 Latin America: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 77 Mexico: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 79 Mexico: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 80 Brazil: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 83 Argentina: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 85 Argentina: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Cancer Biopsy Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product Type
  • Figure 7. Global Cancer Biopsy Market, by Product Type, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Cancer Biopsy Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Cancer Biopsy Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 12. Cancer Biopsy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Cancer Biopsy Market